Leonard Frank X's Form 4/A amendment
AmendedNovoCure Ltd (NVCR) · filed Sep 13, 2022
- Accession no.
- 0001645113-22-000081
- Filed
- Sep 13, 2022
- Trade date
- Sep 8, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 12, 2022
This filing lists 1 non-derivative transaction. Open-market sales total $550.3K. It was filed 5 days after the trade.
This amendment replaces 0001645113-22-000080 (filed Sep 12, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Frank XCIK 0001822879 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2022 | Ordinary Shares | SSaleDisposed | −6,754 | $81.48 | −$550,315.92 | 77,396 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Amending original Form 4 filed on September 12, 2022 to add additional transaction inadvertently omitted.
- F2
Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard.